| SpectraBase Spectrum ID |
2TYEIkVgbw |
| Name |
1-(2-Fluorobenzyl)-4-(2-dimethylaminoethyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024-2025 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
265.195425948 u |
| Formula |
C15H24FN3 |
| InChI |
InChI=1S/C15H24FN3/c1-17(2)7-8-18-9-11-19(12-10-18)13-14-5-3-4-6-15(14)16/h3-6H,7-13H2,1-2H3 |
| InChIKey |
IOLKXGSILGZAPE-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
265.376 g/mol |
| Nominal Mass |
265 u |
| Quality |
952 |
| Retention Index |
1858 |
| SMILES |
C=1(C(=CC=CC1)F)CN1CCN(CC1)CCN(C)C |
| SPLASH |
splash10-0a4i-9860000000-81f290aa25ac67f3e90b |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(2-fluorobenzyl)-4-(2-dimethylaminoethyl)
2-(4-(2-fluorobenzyl)piperazin-1-yl)-N,N-dimethylethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011194 |
